Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
暂无分享,去创建一个
A. Rovira | R. Pelayo | À. Rovira | X. Montalban | M. Tintoré | J. Sastre-Garriga | N. Téllez | M. Tintoré | J. Río | A. Rovira | M. Comabella | C. Tur | R. Pelayo | X. Montalban | C. Nos | H. Perkal | J. Sastre-Garriga | M. Tintoré | J. Río | C. Tur | C. Nos | N. Téllez | H. Perkal | M. Comabella
[1] H. Ulmer,et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. , 2003, The New England journal of medicine.
[2] À. Rovira,et al. Antimyelin antibodies with no progression to multiple sclerosis. , 2007, The New England journal of medicine.
[3] G. Bernardi,et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[4] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[5] R. Beck,et al. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. , 1996, Neurology.
[6] J. Hillert,et al. Optic neuritis , 1998, Neurology.
[7] R. Beck,et al. Cerebrospinal fluid in acute optic neuritis , 1996, Neurology.
[8] J. Olesen,et al. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis , 1992, Acta neurologica Scandinavica.
[9] W. Mcdonald,et al. A study of oligoclonal band negative multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[10] J. Masjuán,et al. Clinically isolated syndromes , 2006, Neurology.
[11] À. Rovira,et al. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS , 2001, Multiple sclerosis.
[12] W. Tourtellotte,et al. Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis , 1998, Journal of the Neurological Sciences.
[13] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[14] H. Link,et al. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. , 1980, Journal of neurology, neurosurgery, and psychiatry.
[15] À. Rovira,et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes , 2006, Neurology.
[16] D. Paty,et al. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis. , 1983, Brain : a journal of neurology.
[17] J. De Pedro-Cuesta,et al. Predicting multiple sclerosis at optic neuritis onset , 2003, Multiple sclerosis.
[18] J. Hillert,et al. Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct , 2006, Neurology.
[19] G. Comi,et al. Paraclinical tests in acute‐onset optic neuritis: basal data and results of a short follow‐up , 1991, Acta neurologica Scandinavica.
[20] Thomas Berger,et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. , 2007, The New England journal of medicine.
[21] V. Torri,et al. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests , 1999, Journal of Neurology.
[22] J. Masjuán,et al. Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS , 2002, Neurology.